Active substanceDeproteinized hemoderivatDeproteinized hemoderivat
Similar drugsTo uncover
  • Actovegin®
    solution d / infusion 
  • Actovegin®
    solution for injections 
  • Actovegin
    solution for injections 
    Nycomed Austria GmbH     Austria
  • Actovegin
    pills inwards 
  • Actovegin®
    solution d / infusion 
    Nycomed Austria GmbH     Austria
  • Actovegin®
    ointment externally 
  • Actovegin®
    gel externally 
  • Actovegin®
    cream externally 
  • Solcoseryl
    ointment externally 
  • Solcoseryl
    gel externally 
  • Solcoseryl
    solution w / m in / in 
  • Solcoseryl
    gel d / eye 
  • Dosage form: & nbsppasta for topical application
    Composition:

    Composition per 1 g

    Active Ingredients

    Solcoseryl - deproteinized dialysate from the blood of healthy dairy calves (Bos Taurus), chemically and biologically standardized (in terms of dry matter) 2.125 mg

    Polydocanol 600 10,000 mg

    Preservatives

    Methyl parahydroxybenzoate (E218) 1.800 mg

    Propyl parahydroxybenzoate (E 216) 0.200 mg

    Excipients

    Sodium carboxymethylcellulose 22.875 mg

    Mint peppery oil 2,925 mg

    Menthol 0.075 mg

    Basis of paste

    (sodium carboxymethylcellulose, gelatin, pectin, polyethylene 350.000, liquid paraffin) 960,000 mg.

    Description:

    Pale beige granular homogeneous, easily distributed mass with the smell of peppermint.

    Pharmacotherapeutic group:Stimulator of tissue regeneration
    ATX: & nbsp
  • Other preparations for the treatment of diseases of the oral cavity
  • Pharmacodynamics:

    Solcoseryl is a chemically and biologically standardized deproteinized dialysate derived from the blood of healthy dairy calves by ultrafiltration. Solcoseryl contains a wide range of natural low molecular weight compounds up to 5000 Dalton: glycolipids, nucleosides and nucleotides, amino acids, oligopeptides, microelements, electrolytes, intermediate products of carbohydrate and fat metabolism. Solcoseryl activates the transport of oxygen and nutrients at the cellular level, increases the oxygen consumption of the cell, stimulates the synthesis of ATP,strengthens the proliferation of reversibly damaged cells, especially under conditions of hypoxia, thereby accelerating the processes of wound healing. Solcoseryl stimulates angiogenesis, promotes revascularization of ischemic tissues, as well as the creation of conditions favorable for collagen synthesis and growth of fresh granulation tissue, accelerates re-epithelialization and wound closure. Solcoseryl also has a membrane-stabilizing and cytoprotective effect.

    Polidocanol 600 is a local anesthetic; acts in the peripheral nerve endings, causing their reversible blocking. Has a fast and prolonged local anesthetic effect. After the paste is applied to the oral mucosa, the pain is eliminated after 2-5 minutes; anesthesia persists for 3-5 hours.

    Solkoseril dental adhesive paste forms a protective therapeutic layer on the affected area of ​​the oral mucosa and protects it from mechanical and chemical damage within 3-5 hours, performing the function of a medicinal bandage.

    Pharmacokinetics:

    Not studied.

    Indications:

    Solcoseryl dental adhesive paste is used in patients of all age groups for local acceleration of healing,anesthesia and protection of the wound surface in the following diseases and conditions:

    - Gingivitis and paradontic diseases, including after surgical interventions, implant placement, removal of tartar

    - bedsores from removable dentures in the period of adaptation to them

    - Alveolitis

    - Stomatitis

    - Lesions of the oral mucosa with pemphigus

    - Aphthuses

    - Zaeda

    Contraindications:

    Individual sensitivity to any of the components of the drug, including free parahydroxybenzoic acid (E 210), the presence of a residual amount of which is due to the features of the manufacturing process in the manufacture of the drug.

    Pregnancy and lactation:

    There are no contraindications to the use of the drug Solcoseryl dental adhesive paste during pregnancy and lactation, although no special controlled studies on the safety of the drug in women during pregnancy and lactation have been conducted.

    Dosing and Administration:

    The drug is intended for topical application in the mucous membrane of the oral cavity.

    The affected surface of the mucous membrane must be previously dried with a bath or gauze swab.A strip of paste about 0.5 cm long should be applied, without rubbing, onto the mucous membrane with a thin layer with the help of a finger or a cotton swab, and then slightly moistened with water. The procedure is repeated 3-5 times a day after meals and at bedtime. Treatment is carried out until the symptoms disappear.

    Solkoseril dental adhesive paste forms a protective therapeutic layer on the affected area of ​​the oral mucosa and protects it from mechanical and chemical damage within 3-5 hours. When applying the paste on the undried mucous it is possible to reduce the duration of the therapeutic effect.

    When treating bedsores from removable dentures, apply paste on a dry prosthesis and moisten with water.

    The recommended course dose is 1 tube (5 g).

    Side effects:

    Change in taste.

    Allergic reactions (local edema) are possible, in the event of which it is necessary to stop using the drug and consult a doctor.

    Overdose:

    Data on the effects of drug overdose are absent.

    Interaction:

    Until now, there have been no cases of interaction of Solcoseryl dental adhesive paste with other drugs.

    With the simultaneous appointment of Solcoseryl dental adhesive paste and other preparations in the form of rinses, the paste should be applied after the application of these drugs.

    Special instructions:

    Solcoseryl dental adhesive paste should not be placed in the wound cavity, which is formed due to the removal of molars, wisdom teeth, as well as apicotomy (tooth tip resection), if the edges of the tooth socket are tightened with subsequent suturing.

    Solcoseryl dental adhesive paste does not contain anti-infective ingredients. In case of acute infection of the affected area of ​​the oral mucosa that is to be treated with this drug, it is necessary to conduct preliminary medical treatment / treatment of the affected area, aimed at eliminating the symptoms of inflammation.

    There are no restrictions on the use of the drug in children.

    There are no restrictions on the use of the drug in elderly patients.

    Form release / dosage:Paste for topical application.
    Packaging:

    5 grams per aluminum tubes. Tuba with the instruction for use is put in a cardboard box.

    Storage conditions:

    Store at a temperature not exceeding 30 ° C in a place inaccessible to children.

    The grainy-dry consistency of the paste provides its optimum adhesive properties and is not a sign of deterioration in the quality of the preparation. When the tube is opened, it is possible to extract oil, which is also not a sign of deterioration in the quality of the drug.

    Shelf life:

    4 years. It is not recommended to use the drug after the expiry date indicated on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N 015194/01
    Date of registration:18.07.2008
    The owner of the registration certificate:MEDA Pharmaceuticals Switzerland GmbHMEDA Pharmaceuticals Switzerland GmbH Switzerland
    Manufacturer: & nbsp
    Representation: & nbspMEDA PHARMA LLCMEDA PHARMA LLC
    Information update date: & nbsp21.12.2015
    Illustrated instructions
      Instructions
      Up